LOM Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
LOM Asset Management's NVS Position: Q2 2026 in Review
LOM Asset Management increased its Novartis (NVS) stake by 52% in Q2 2026, buying an estimated $36.7K and bringing the position to 720 shares worth $113K. The position accounts for 0.03% of the portfolio, ranked #185.
LOM Asset Management first reported a position in NVS in Q3 2025 and has held it in 4 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- LOM Asset Management held 720 shares of Novartis worth $113K as of Q2 2026.
- LOM Asset Management bought 245 Novartis shares in Q2 2026, an estimated $36.7K.
- Novartis made up 0.03% of LOM Asset Management's portfolio in Q2 2026, its #185 holding.
- LOM Asset Management first reported a position in Novartis in Q3 2025 and has held it in 4 quarters since.
- 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on LOM Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.